IRVINE, Calif.--(BUSINESS WIRE)--Endologix LLC, a privately held global medical device company dedicated to providing disruptive therapies for the interventional treatment of vascular disease, has ...
IRVINE, Calif.--(BUSINESS WIRE)--Endologix LLC, a privately held global medical device company, dedicated to improving patients’ lives with innovative interventional treatments for vascular disease, ...
Dr. Matt Thompson, Chief Medical Officer of Endologix Inc. commented, “On September 28, 2017, the FDA issued a letter to health care professionals (“HCPs”) regarding Type III endoleaks after ...
Endologix seems to be taking a proactive stance to nip an AFX manufacturing glitch in the bud, but analysts wonder if the company's portfolio is just too broad. The company expects to share more ...
The US Food and Drug Administration (FDA) has issued an update to its January 2022 safety communication on the use of Endologix AFX endovascular grafts to treat patients with abdominal aortic aneurysm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results